Updates from The Motley Fool

Latest updates on EPIRUS Biopharmaceuticals from Fool.com.

Stock Performance

EPRS vs. S&P 500 | 2 Year Performance
EPRS 1-Day Stock Chart
EPRS 5-Day Stock Chart
EPRS 1-Month Stock Chart
EPRS 3-Month Stock Chart
EPRS 6-Month Stock Chart
EPRS 1-Year Stock Chart
EPRS 2-Year Stock Chart
EPRS 5-Year Stock Chart
View Interactive EPRS Charts
Sponsored by

Key Data Points

Primary metrics and data points about EPIRUS Biopharmaceuticals.
Current Price: $0.60
Prev Close: $0.60
Open: $0.64
Bid: $0.57
Ask: $0.66
Day's Range: $0.57 - $0.66
52wk Range: $0.53 - $8.75
Volume: 192,362
Avg Vol 334,382
Market Cap: $14.56M
P/E (ttm): -0.22
EPS (ttm): -$2.56
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about EPIRUS Biopharmaceuticals.
CAPS Rating 4 out of 5
266 Outperform
14 Underperform
CAPS All Stars
29 Outperform
2 Underperform

How do you think EPIRUS Biopharmaceuticals will perform against the market?

You pick for EPIRUS Biopharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for EPIRUS Biopharmaceuticals.

A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers